95 related articles for article (PubMed ID: 15941768)
1. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.
Ortega-Gutiérrez S; Molina-Holgado E; Arévalo-Martín A; Correa F; Viso A; López-Rodríguez ML; Di Marzo V; Guaza C
FASEB J; 2005 Aug; 19(10):1338-40. PubMed ID: 15941768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.
Mestre L; Correa F; Arévalo-Martín A; Molina-Holgado E; Valenti M; Ortar G; Di Marzo V; Guaza C
J Neurochem; 2005 Mar; 92(6):1327-39. PubMed ID: 15748152
[TBL] [Abstract][Full Text] [Related]
3. An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.
Loría F; Petrosino S; Hernangómez M; Mestre L; Spagnolo A; Correa F; Di Marzo V; Docagne F; Guaza C
Neurobiol Dis; 2010 Jan; 37(1):166-76. PubMed ID: 19815071
[TBL] [Abstract][Full Text] [Related]
4. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
[TBL] [Abstract][Full Text] [Related]
5. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.
Ortega-Gutiérrez S; Molina-Holgado E; Guaza C
Glia; 2005 Nov; 52(2):163-8. PubMed ID: 15920730
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.
Correa F; Hernangómez-Herrero M; Mestre L; Loría F; Docagne F; Guaza C
Brain Behav Immun; 2011 May; 25(4):736-49. PubMed ID: 21310228
[TBL] [Abstract][Full Text] [Related]
7. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Cabranes A; Pryce G; Baker D; López-Rodríguez M; Ramos JA
Eur Neuropsychopharmacol; 2006 Jan; 16(1):7-18. PubMed ID: 16006105
[TBL] [Abstract][Full Text] [Related]
8. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway.
Molina-Holgado F; Molina-Holgado E; Guaza C
FEBS Lett; 1998 Aug; 433(1-2):139-42. PubMed ID: 9738948
[TBL] [Abstract][Full Text] [Related]
9. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Hernangómez M; Mestre L; Correa FG; Loría F; Mecha M; Iñigo PM; Docagne F; Williams RO; Borrell J; Guaza C
Glia; 2012 Sep; 60(9):1437-50. PubMed ID: 22653796
[TBL] [Abstract][Full Text] [Related]
10. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
Hasanein P; Javanmardi K
Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
12. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Iwahashi T; Inoue A; Koh CS; Shin TK; Kim BS
Cell Immunol; 1999 Jun; 194(2):186-93. PubMed ID: 10383821
[TBL] [Abstract][Full Text] [Related]
13. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].
La Rana G; Russo R; Campolongo P; Bortolato M; Mangieri RA; Cuomo V; Iacono A; Raso GM; Meli R; Piomelli D; Calignano A
J Pharmacol Exp Ther; 2006 Jun; 317(3):1365-71. PubMed ID: 16510698
[TBL] [Abstract][Full Text] [Related]
14. A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.
Correa F; Docagne F; Mestre L; Clemente D; Hernangómez M; Loría F; Guaza C
Biochem Pharmacol; 2009 Jan; 77(1):86-100. PubMed ID: 18848818
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
16. 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
Feliú A; Bonilla Del Río I; Carrillo-Salinas FJ; Hernández-Torres G; Mestre L; Puente N; Ortega-Gutiérrez S; López-Rodríguez ML; Grandes P; Mecha M; Guaza C
J Neurosci; 2017 Aug; 37(35):8385-8398. PubMed ID: 28751457
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
[TBL] [Abstract][Full Text] [Related]
18. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
19. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA
Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Yanagisawa S; Takeichi N; Kaneyama T; Yagita H; Taniguchi S; Kim BS; Koh CS
Brain Res; 2010 Mar; 1317():236-45. PubMed ID: 20045400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
